{"version":"1.0","type":"link","title":"Efficacy of disitamab vedotin-based therapy in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis.","author_name":"Ye J 외","author_url":"https://prs-insight.online/author/Ye%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/75320","thumbnail_width":1200,"thumbnail_height":630}